PE Giants Target Romsons: India’s MedTech Boom Attracts Investors

Significant global private equity (PE) players are currently evaluating a minority stake acquisition in Romsons Group, a leading Indian medical device manufacturer. This potential deal, valued at approximately Rs 1,200 crore, exemplifies the surging interest and substantial medical device investment within India’s rapidly expanding medtech sector. As a prominent player in medical consumables, Romsons has attracted attention from major PE firms like Warburg Pincus and TA Associates, signifying a pivotal moment for the industry. [13]

Romsons Group, established in 1952 and based in Agra, stands as one of the largest manufacturers of medical consumables in India. Their extensive product portfolio includes essential items such as syringes, catheters, and infusion sets. The company has successfully cultivated a wide distribution network, reaching hospitals across India and exporting to over 100 countries globally. This widespread reach and specialization in high-volume, low-cost products make Romsons a highly attractive target for investors seeking scale and international market access. [13]

Driving Medical Device Investment in India

The Indian medical device industry demonstrates robust growth, transforming from import reliance to a significant manufacturing hub. The market, valued at approximately $12 billion in FY 2023-24, is projected to reach $50 billion by 2030. [5, 7] Several factors fuel this growth, including increasing healthcare demand, a growing middle class, and supportive government initiatives like the Production Linked Incentive (PLI) scheme. [4, 5, 12] Consequently, these elements create a favorable environment for sustained medical device investment. Moreover, the sector has seen a marked uptick in domestic production, supported by fresh capital from both local and multinational firms. [13] Many experts compare this trend to the generics industry’s rise in the 1990s, recognizing India’s competitive advantages in production costs and skilled labor. [2]

Over the past few years, the medtech sector has experienced a flurry of private equity and venture capital investments. This influx of capital has significantly bolstered the local manufacturing footprint across India. Deals in the Indian medical devices space have surged, with a 3.3 times increase compared to pre-COVID-19 levels since 2017. [2, 4] This growth underscores the increasing confidence investors place in India’s healthcare market potential. Indeed, medical devices’ contribution to total deal value has doubled from 6% between 2017 and 2020 to 11% between 2021 and mid-2024. [2, 4]

Notable Private Equity Engagements

Prominent private equity firms have actively pursued opportunities in the Indian medical device sector. Besides Warburg Pincus and TA Associates eyeing Romsons, other significant investments highlight this trend. For instance, Abu Dhabi Investment Authority (ADIA) invested $200 million for a 3% stake in Meril, another leading medtech company. [13] Furthermore, Warburg Pincus previously acquired a majority stake in Appasamy Associates, an ophthalmic equipment company, for $300 million. [13] Other notable deals include Samara Capital’s $150 million investment in stent manufacturer SMT and Everstone Capital’s funding in Translumina, another stent producer. [13]

These investments align with a broader shift towards strengthening domestic ecosystems and achieving national self-reliance, particularly in manufacturing. [12] The Indian market segments include electronic equipment, disposables & consumables, in-vitro diagnostics, implants, and surgical instruments. [7] Manufacturers benefit from lower production costs and a skilled workforce, contributing to India’s position as one of the top 5-10 manufacturers of medical consumables worldwide. [2]

Frequently Asked Questions

Q1: What is the current value and projected growth of India’s medical device market?

The Indian medical device market is currently valued at approximately $12 billion in FY 2023-24 and is projected to reach $50 billion by 2030, exhibiting robust growth. [5, 7]

Q2: Which private equity firms are showing interest in Romsons Group?

Global private equity firms, including Warburg Pincus and TA Associates, are among the frontrunners eyeing a minority stake in Romsons Group. [13]

Q3: What types of products does Romsons Group manufacture?

Romsons Group specializes in medical consumables, with a product portfolio that includes syringes, catheters, infusion sets, and other disposable medical devices. [13, 16]

References

1. Private equity majors eye minority stake in medical device company – ETHealthworld
2. PE deals in India’s MedTech industry trebled in 4 years – Medical Buyer. [2]
3. India MedTech 2024: Key Insights and Growth Opportunities in Medical Technology. [3]
4. Private Equity Firms Targeting India’s Medical Device Market | Medica Times. [4]
5. India’s Medical Devices Industry: Investor Outlook – India Briefing. [5]
6. India’s MedTech transformation: paving the path to global leadership – EY. [7]
7. Private equity deals in medical devices in India decreased in Q3 2024. [8]
8. Romsons Group Financials | Company Details – Tofler. [9]
9. Romsons Group – Overview, Competitors, News, and Employees | Clodura.AI. [10]
10. Indian Medical Devices Market, Size, Trends and Forecast to 2028 – Ken Research. [11]
11. Indian private equity enjoys the spotlight. [12]
12. India’s MedTech industry – The renaissance of a sector – Medical Buyer. [15]
13. Romsons Group Private Limited – Manufacturer from Agra, India | About Us – IndiaMART. [16]

Disclaimer: This article was automatically generated from publicly available sources and is provided for informational and educational purposes only. OC Academy does not exercise editorial control or claim authorship over this content. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider and refer to current local and national clinical guidelines.